BIOMAT Database Logo BIOMAT Database Logo

[Indications for drug therapy of chronic active hepatitis and posthepatitis liver cirrhosis]. 1985

G Strohmeyer, and H J Lübke

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Strohmeyer, and H J Lübke
[Behavior of serum glutamic oxalacetic transaminase in chronic recurrent hepatitis and active posthepatitis liver cirrhosis under prednisone therapy; preliminary report].
September 1958, Klinische Wochenschrift,
G Strohmeyer, and H J Lübke
[Medical insurance problems in chronic hepatitis and posthepatitis cirrhosis].
December 1965, Medizinische Klinik,
G Strohmeyer, and H J Lübke
[Indications for treatment of chronic hepatitis and liver cirrhosis and their complications. 1. Treatment of chronic hepatitis and liver cirrhosis].
June 1974, Zeitschrift fur arztliche Fortbildung,
G Strohmeyer, and H J Lübke
[CLINICAL, BIOCHEMICAL AND ANATOMOPATHOLOGICAL STUDY OF CHRONIC HEPATITIS AND POSTHEPATITIS CIRRHOSIS].
January 1964, Verhandelingen - Koninklijke Vlaamse Academie voor Geneeskunde van Belgie,
G Strohmeyer, and H J Lübke
Chronic active hepatitis and cirrhosis of the liver.
July 1972, Journal of the Indian Medical Association,
G Strohmeyer, and H J Lübke
[Hepatitis and posthepatitis liver diseases].
January 1959, Gastroenterologia,
G Strohmeyer, and H J Lübke
[Therapy of chronic hepatitis and liver cirrhosis].
October 1959, Medizinische Klinik,
G Strohmeyer, and H J Lübke
[THERAPY OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS].
January 1965, Internistische Praxis,
G Strohmeyer, and H J Lübke
[Indications for surgical treatment of chronic hepatitis and cirrhosis of the liver].
January 1986, Klinicheskaia khirurgiia,
G Strohmeyer, and H J Lübke
[Functional state of the pancreas in acute and chronic epidemic hepatitis and posthepatitis cirrhosis of the liver].
June 1972, Sovetskaia meditsina,
Copied contents to your clipboard!